As disruption of GC-C signaling in the earliest stages of colorectal cancer is a consequence of hormone insufficiency, it is to be assumed that hormone replacement therapy may be able to prevent or treat colon cancer. Here, GUCY2C is linked to malignant colon neoplasm.